Serial Number | 79278137 |
Word Mark | BRIGHTGENE |
Filing Date | Monday, October 28, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, August 31, 2021 |
Registration Number | 6465606 |
Registration Date | Tuesday, August 31, 2021 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 15, 2021 |
Goods and Services | Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicinal preparations for the mouth in the form of tablets or compressed tablets for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicines for human purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; biochemical medical drug for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical preparations for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; drugs for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; active pharmaceutical ingredients for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders |
Pseudo Mark | BRIGHT GENE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 10, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | BrightGene Bio-Medical Technology Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | CN |
Party Name | BrightGene Bio-Medical Technology Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | CN |
Party Name | BrightGene Bio-Medical Technology Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | CN |
Event Date | Event Description |
Sunday, February 27, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Monday, February 7, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
Monday, February 7, 2022 | FINAL DISPOSITION PROCESSED |
Tuesday, November 30, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, August 31, 2021 | REGISTERED-PRINCIPAL REGISTER |
Saturday, July 24, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Wednesday, July 7, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, July 7, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Tuesday, June 15, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 15, 2021 | PUBLISHED FOR OPPOSITION |
Sunday, June 13, 2021 | NOTIFICATION PROCESSED BY IB |
Wednesday, May 26, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, May 26, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, May 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, May 10, 2021 | ASSIGNED TO LIE |
Monday, May 10, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, October 20, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, October 20, 2020 | LETTER OF SUSPENSION E-MAILED |
Tuesday, October 20, 2020 | SUSPENSION LETTER WRITTEN |
Friday, September 18, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, September 17, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, September 17, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, September 17, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, September 17, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, September 17, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, September 17, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, September 17, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, April 17, 2020 | REFUSAL PROCESSED BY IB |
Friday, March 27, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, March 26, 2020 | REFUSAL PROCESSED BY MPU |
Thursday, March 12, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, March 11, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, March 10, 2020 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
Wednesday, February 19, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, February 18, 2020 | NON-FINAL ACTION WRITTEN |
Friday, February 14, 2020 | APPLICATION FILING RECEIPT MAILED |
Monday, February 10, 2020 | ASSIGNED TO EXAMINER |
Monday, February 10, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, February 6, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |